ALX Oncology Holdings Inc at JPMorgan Healthcare Conference Transcript
Good afternoon. Thank you all for joining us here today. My name is Henry Jiang. I'm with the banking team here at JPMorgan, and it's my pleasure to be introducing ALX Oncology today. Joining us on stage and presenting today will be Jason Lettmann, CEO; as well as Barbara Klencke, Chief Medical Officer.
Just a reminder that we'll have time for questions at the end of the session. So please wait until then for any questions, and we'll get you a microphone.
But without further ado, I'll pass it over to you, Jason.
Great. Thanks, Henry. Thanks for having us, and thanks to JPMorgan for the week, and appreciate you all spending some time. We heard that Thursday is the new Monday at JPMorgan. So thank you, thank you all.
Here are our forward-looking statements. So really excited to be here. We've had a really exciting week, I think, for ALX. We're coming off an incredible year for the company, a year in which we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
